Editors’ Picks, April 2024: Targeting Metabolism, KRAS, and More
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
As the candy supply dwindles, and the Halloween sugar rush tapers off, get re-energized by the latest edition of...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...